Cutting through the months of data-wrangling that plague genomics and bioinformatics researchers, OmicsBank has secured $2.3M in seed funding.
The investment, led by Redesign Health, will further OmicsBank's work in providing research teams, biotech companies, and academic labs with a streamlined way to access, link, and work with high-quality omics and clinical data. The company aims to eliminate the significant overhead typically involved in building data pipelines from scratch, offering a reliable data foundation for studies.
